An update on nonspecific interstitial pneumonia

Clinical Pulmonary Medicine

Volumn 17, Issue 3, 2010, Pages 122-128

  Antin Ozerkis, Danielle ^a,c   Rubinowitz, Ami ^b  

^a Section of Pulmonary and Critical Care Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Idiopathic interstitial pneumonia (IIP); Interstitial lung disease (ILD); Nonspecific interstitial pneumonia (NSIP)

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; AZATHIOPRINE; BIOLOGICAL PRODUCT; BLEOMYCIN; BUSULFAN; CARDIOVASCULAR AGENT; CEPHALOSPORIN DERIVATIVE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GEFITINIB; GEMCITABINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERFERON; IRINOTECAN; LEFLUNOMIDE; MINOCYCLINE; MITOMYCIN C; MYCOPHENOLIC ACID; NAVELBINE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RETINOIC ACID; SALAZOSULFAPYRIDINE; TACROLIMUS; UNINDEXED DRUG;

ANAMNESIS; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; ENVIRONMENTAL EXPOSURE; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LUNG FIBROSIS; MEDICAL SOCIETY; OCCUPATIONAL EXPOSURE; PHYSICAL EXAMINATION; PROGNOSIS; RADIODIAGNOSIS; REVIEW;

EID: 77952367192     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/CPM.0b013e3181daae17     Document Type: Review

References (74)

1. Liebow A, Carrington C. The interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M, eds. Frontiers for Pulmonary Radiology. New York, NY: Grune and Stratton; 1969:102-141.
2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277-304.
3. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am J Surg Pathol. 1994;18:136-147.
4. Katzenstein AL, Mukhopadhyay S, Myers JL. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol. 2008;39:1275-1294.
5. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis- dermatomyositisassociated interstitial lung disease. Am J Respir Crit Care Med. 2001;164:1182-1185.
6. Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med. 2002;165:1581-1586.
7. Tansey D, Wells AU, Colby TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology. 2004;44:585-596.
8. Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005;127:2019-2027.
9. Churg A, Muller NL, Flint J, et al. Chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2006;30:201-208.
10. Rossi SE, Erasmus JJ, McAdams HP, et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics. 2000;20:1245-1259.
11. Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med. 1999;160:899-905.
12. Nagai S, Kitaichi M, Itoh H, et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J. 1998;12:1010-1019.
13. Travis WD, Hunninghake G, King TE Jr, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008;177:1338-1347.
14. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;157:199-203.
15. Nicholson AG, Colby TV, du Bois RM, et al. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med. 2000;162:2213-2217.
16. Flaherty KR, Martinez FJ. Nonspecific interstitial pneumonia. Semin Respir Crit Care Med. 2006;27:652-658.
17. Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med. 2007;176:691-697.
18. Kim DS, Nagai S. Idiopathic nonspecific interstitial pneumonia: an unrecognized autoimmune disease? Am J Respir Crit Care Med. 2007;176:632-633.
19. Bourke SJ, Banham SW, Carter R, et al. Longitudinal course of extrinsic allergic alveolitis in pigeon breeders. Thorax. 1989;44:415-418.
20. Warren CP, Tse KS. Extrinsic allergic alveolitis owing to hypersensitivity to chickens-significance of sputum precipitins. Am Rev Respir Dis. 1974;109:672-677.
21. Bourke SJ, Dalphin JC, Boyd G, et al. Hypersensitivity pneumonitis: current concepts. Eur Respir J Suppl. 2001;32:81s-92s.
22. Ganier M, Lieberman P, Fink J, et al. Humidifier lung: an outbreak in office workers. Chest. 1980;77:183-187.
23. Huuskonen MS, Husman K, Jarvisalo J, et al. Extrinsic allergic alveolitis in the tobacco industry. Br J Ind Med. 1984;41:77-83.
24. Malmberg P, Rask-Andersen A, Rosenhall L. Exposure to microorganisms associated with allergic alveolitis and febrile reactions to mold dust in farmers. Chest. 1993;103:1202-1209.
25. Marcer G, Franchini M, Gemignani C, et al. Cheese workers' lung. Allergy. 1996;51:959-960.
26. Moore JE, Convery RP, Millar BC, et al. Hypersensitivity pneumonitis associated with mushroom worker's lung: an update on the clinical significance of the importation of exotic mushroom varieties. Int Arch Allergy Immunol. 2005;136:98-102.
27. Veillette M, Cormier Y, Israel-Assayaq E, et al. Hypersensitivity pneumonitis in a hardwood processing plant related to heavy mold exposure. J Occup Environ Hyg. 2006;3:301-307.
28. Dykewicz MS, Laufer P, Patterson R, et al. Woodman's disease: hypersensitivity pneumonitis from cutting live trees. J Allergy Clin Immunol. 1988;81:455-460.
29. Blyth W, Grant IW, Blackadder ES, et al. Fungal antigens as a source of sensitization and respiratory disease in Scottish maltworkers. Clin Allergy. 1977;7:549-562.
30. Romeo L, Dalle Molle K, Zanoni G, et al. Respiratory health effects and immunological response to Tthermoactinomyces among sugar cane workers in Nicaragua. Int J Occup Environ Health. 2009;15:249-254.
31. Carroll KB, Pepys J, Longbottom JL, et al. Extrinsic allergic alveolitis due to rat serum proteins. Clin Allergy. 1975;5:443-456.
32. Rosenman KD. Asthma, hypersensitivity pneumonitis and other respiratory diseases caused by metalworking fluids. Curr Opin Allergy Clin Immunol. 2009;9:97-102.
33. Hanak V, Kalra S, Aksamit TR, et al. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med. 2006;100:610-615.
34. Camus P, Bonniaud P, Fanton A, et al. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med. 2004;25:479-519, vi.
35. Alcorn N, Saunders S, Madhok R. Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing. Drug Saf. 2009;32:1123-1134.
36. Lantuejoul S, Brambilla E, Brambilla C, et al. Statin-induced fibrotic nonspecific interstitial pneumonia. Eur Respir J. 2002;19:577-580.
37. O'Donnell D. Physiology of interstitial lung disease. In: Schwarz MI, ed. Interstitial Lung Disease. Ontario, Canada: BC Decker; 2003.
38. Hughes JM, Lockwood DN, Jones HA, et al. DLCO/Q and diffusion limitation at rest and on exercise in patients with interstitial fibrosis. Respir Physiol. 1991;83:155-166.
39. Harris-Eze AO, Sridhar G, Clemens RE, et al. Oxygen improves maximal exercise performance in interstitial lung disease. Am J Respir Crit Care Med. 1994;150:1616-1622. (Pubitemid 24361736)
40. Agarwal S, Richardson B, Krishnan V, et al. Interstitial lung disease and sleep: what is known? Sleep Med. 2009;10:947-951.
41. Bye PT, Issa F, Berthon-Jones M, et al. Studies of oxygenation during sleep in patients with interstitial lung disease. Am Rev Respir Dis. 1984;129:27-32.
42. Lancaster LH, Mason WR, Parnell JA, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest. 2009;136:772-778.
43. Yang Y, Fujita J, Tokuda M, et al. Chronological evaluation of the onset of histologically confirmed interstitial pneumonia associated with polymyositis/dermatomyositis. Intern Med. 2002;41:1135-1141.
44. Scribner GH, Barboriak JJ, Fink JN. Prevalence of precipitins in groups at risk of developing hypersensitivity pneumonitis. Clin Allergy. 1980;10:91-95.
45. Kligerman SJ, Groshong S, Brown KK, et al. Nonspecific interstitial pneumonia: radiologic, clinical, and pathologic considerations. Radiographics. 2009;29:73-87.
46. Kim TS, Lee KS, Chung MP, et al. Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings. Am J Roentgenol. 1998;171:1645-1650.
47. Park JS, Lee KS, Kim JS, et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology. 1995;195:645-648.
48. Katoh T, Andoh T, Mikawa K, et al. Computed tomographic findings in non-specific interstitial pneumonia/fibrosis. Respirology. 1998;3:69-75.
49. Lynch DA, Travis WD, Muller NL, et al. Idiopathic interstitial pneumonias: CT features. Radiology. 2005;236:10-21.
50. Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest. 2003;124:1215-1223.
51. Silva CI, Muller NL, Hansell DM, et al. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology. 2008;247:251-259.
52. Sumikawa H, Johkoh T, Ichikado K, et al. Nonspecific interstitial pneumonia: histologic correlation with high-resolution CT in 29 patients. Eur J Radiol. 2009;70:35-40.
53. Shin KM, Lee KS, Chung MP, et al. Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study. Radiology. 2008;249:328-337.
54. Collard HR, King TE Jr. Demystifying idiopathic interstitial pneumonia. Arch Intern Med. 2003;163:17-29.
55. Hartman TE, Swensen SJ, Hansell DM, et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology. 2000;217:701-705.
56. Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax. 2003;58:143-148.
57. Collard HR, King TE Jr. The clinical significance of histopathologic subgroups in idiopathic interstitial pneumonia: is surgical lung biopsy essential? Semin Respir Crit Care Med. 2001;22:347-356.
58. Chang AC, Yee J, Orringer MB, et al. Diagnostic thoracoscopic lung biopsy: an outpatient experience. Ann Thorac Surg. 2002;74:1942-1946; discussion 1946-1947.
59. Ooi A, Iyenger S, Ferguson J, et al. VATS lung biopsy in suspected, diffuse interstitial lung disease provides diagnosis, and alters management strategies. Heart Lung Circ. 2005;14:90-92.
60. Kreider ME, Hansen-Flaschen J, Ahmad NN, et al. Complications of videoassisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann Thorac Surg. 2007;83:1140-1144.
61. Park JH, Kim DK, Kim DS, et al. Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia. Eur J Cardiothorac Surg. 2007;31:1115-1119.
62. Lettieri CJ, Veerappan GR, Helman DL, et al. Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest. 2005;127:1600-1605.
63. Myers JL, Katzenstein AL. Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies. Histopathology. 2009;54:90-103.
64. Myers JL. Nonspecific interstitial pneumonia: pathologic features and clinical implications. Semin Diagn Pathol. 2007;24:183-187.
65. Travis WD, Matsui K, Moss J, et al. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol. 2000;24:19-33.
66. Katzenstein AL, Zisman DA, Litzky LA, et al. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol. 2002;26:1567-1577.
67. Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med. 2001;164:1722-1727.
68. Flaherty KR, King TE Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170:904-910.
69. Kondoh Y, Taniguchi H, Yokoi T, et al. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J. 2005;25:528-533.
70. Cottin V, Donsbeck AV, Revel D, et al. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med. 1998;158:1286-1293.
71. Jegal Y, Kim DS, Shim TS, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med. 2005;171:639-644.
72. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med. 2003;168:531-537.
73. Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168:1084-1090.
74. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates:2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25:745-755.